In conclusion, we have created the first diseased human ECTs from hiPSC-derived cardiomyocytes that reveal functional characteristics of BRAF mutant-mediated HCM, including altered contractile properties, accelerated twitch dynamics, and increased sensitivity to beta-adrenergic stimulation, which may reflect an enhanced susceptibility to arrhythmias. Here, BRAF is linked to cardiac arrhythmia.